Medical research charity LifeArc has appointed Melanie Lee, PhD, CBE as its new CEO. Dave Tapolczay, the present CEO, will be retiring from his position after 11 years’ service. Melanie brings to LifeArc a wealth of leadership experience from the biopharmaceutical industry and the medical research charity sector. Her previous role as CSO of BTG followed senior research leadership positions at Glaxo/GlaxoWellcome, Celltech and UCB; non-executive director roles at Lundbeck and BTG and currently at Sanofi, CEO roles at Syntaxin and NightstaRx and chair and deputy chair rrustee appointments at Cancer Research Technology and Cancer Research UK respectively.